Shoppers Drug Mart may have yet to receive its medical cannabis license from Health Canada, but it is moving full steam ahead to make sure it has secured multiple Canadian cannabis suppliers to provide its customers with products.
Tag Archives: TSX
While the province of Newfoundland and Labrador has its key policies in place for recreational legalization and has secured a supply agreement with Canopy Growth Corporation (TSX:WEED) to provide cannabis for the province, it is now ready to hear from prospective cannabis retailers.
LEAMINGTON, Ontario, Feb. 5, 2018 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX: APH or USOTCQB: APHQF) today announced that it entered into a purchase and sale agreement to sell 26,716,025 shares representing all its shares in Liberty Health Sciences Inc. (“Liberty”) that are not subject to Canadian Securities Exchange (“CSE”) escrow requirements.
LEAMINGTON AND TORONTO, Ontario, Feb. 2, 2018 /Weed Wire/ — Aphria Inc. (TSX:APH or OTCQB:APHQF) (“Aphria”) and Liberty Health Sciences Inc. (CSE:LHS or OTCQB:LHSIF) (“Liberty”) jointly announce that they have entered into a definitive agreement (the “Agreement”) with respect to the sale (the “Transaction”) of Aphria’s subsidiary Aphria (Arizona) Inc. and its sole holdings being the minority membership interests in Copperstate Farms, LLC and Copperstate Farms Investors, LLC (collectively “Copperstate”) to Liberty for a purchase price of $20 million (“Purchase Price”).
On Jan. 16, 2018, Canadian cannabis company Canopy Growth Corporation (TSX: WEED) announced its arrangement to provide marijuana to the province of Prince Edward Island.
A Canadian firm is launching an exchange-traded fund that gives investors exposure to the U.S. recreational marijuana market — a sector that’s been largely avoided by other ETFs because of legal uncertainties.
Shoppers Drug Mart marijuana is one step closer to reality after a public Canadian marijuana company announced that it has signed on to be the Canadian pharmacy chain’s second medical marijuana supplier.
It was another big day of gains on Tuesday for the North American Marijuana Index, even as some investors anxiously wait for the Fed to announce an interest rate hike in the next 24 hours.
A healthy day of trading for Canadian cannabis stocks led the North American Marijuana Index to gain several points over Monday’s 169.07 close.
Following market close on Dec. 4, 2017, Aphria Inc. (TSX:APH), an Ontario-based licensed producer of medical cannabis, made headlines when it announced that it had entered into an agreement to be the medical cannabis supplier for Shoppers Drug Mart, a Canadian pharmacy chain.
While Canadian cannabis producers are preparing for the country’s roll out of recreational cannabis, they are also preparing for a potential shift in the market’s landscape.
While New Brunswick marijuana was slated to be supplied by two public companies, the province has added one more licensed producer to the mix.
A large marijuana producer is hopeful that Canadian physicians will use a new test to help patients determine whether medical marijuana treatment would be effective for them.
The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the U.S. and Canada, increased 4% in October.
Shares of Canopy Growth Corp. (TSX:WEED) have climbed a stunning 53.8% month over month as of close on November 1. With all of this in mind, has Canopy established itself as the premier cannabis stock for Canadians?
Drinkable cannabis has been on the rise since the advent of states in America with recreational marijuana legalization and now that Canada is on the brink of implementing recreational legalization, a recently announced strategic relationship has the future of Canadian cannabis beverages looking bright.
SMITHS FALLS, ON and KINGSTON, JAMAICA, Oct. 25, 2017 /Weed Wire/ – Canopy Growth Corporation (TSX: WEED) is pleased to announce that it has launched a strategic partnership in the Jamaican cannabis market as part of its ongoing international expansion.
Marijuana stocks were down sharply in Tuesday’s trading as Toronto Stock Exchange operator TMX Group Limited suggested the exchange is going to start cracking down on marijuana producers engaging in illegal activities south of the border.
Shares of Canadian marijuana company Aphria Inc sank on Tuesday, after the operator of the Toronto Stock Exchange said cannabis companies with U.S. interests would come under heightened scrutiny and could be delisted.
Canada’s TMX Group Ltd (X.TO), operator of the Toronto Stock Exchange, said on Monday that it might delist stocks of marijuana companies with interests in the United States, where their operations are illegal under federal law.
Despite strong opposition from former White House Press Secretary Sean Spicer and Attorney General Jeff Sessions, and the overall limitations imposed by federal illegality in the U.S., 2017 is shaping up to be a great year for the North American cannabis industry.
The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the U.S. and Canada, increased 6% in September on strong Canadian momentum.
On Sept. 15, 2017, the Canadian province of New Brunswick announced during a news conference that Organigram (TSXV:OGI) and Canopy Growth (TSX: WEED), both already licensed producers in Canada’s medical marijuana program, will distribute recreational marijuana to retail stores established by a newly created provincial crown corporation.
VANCOUVER, Aug. 31, 2017 /Weed Wire/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to provide the following operational update.
Canopy Growth Corp. (TSX:WEED) was the first cannabis stock to the market and quickly captured the attention of traders and risk-taking growth investors alike. As a result, shares of Canopy skyrocketed 300% in a span of just a few months last year.
There have been two interesting developments with marijuana producers Aurora Cannabis Inc. (TSXV:ACB) and Aphria Inc. (TSX:APH).
The results for Canopy Growth’s stock have been terrific so far, yielding a return of over 152% since inception. The stock has been performing well despite lacklustre results and frequent losses.
In late May, MedReleaf priced its public offering at just over $7 per share. The marijuana stock IPO raised a whopping $75 million. Unfortunately, things didn’t work out as planned for pot investors or MedReleaf.
MedReleaf Corp. is the latest cannabis stock to hit the TSX. Could they be the spark to reignite the second wave of the green rush?
Canadian band, the Tragically Hip are hoping to get ahead by a few days, partnering with a Canadian medical marijuana company just before it’s set to go public.
On Monday, May 29, 2017, Tweed Inc., a wholly owned subsidiary of Canopy Growth Corporation (TSX:WEED), was evacuated following a small morning fire at the Hershey Chocolate Factory’s former Visitor Center, which the medical marijuana company is currently renovating.
The recently debuted marijuana stock ETF, the Horizons Medical Marijuana Life Sciences ETF, has lost value for those who’ve decided to take the plunge.
Canopy Growth Corp.’s now down approximately 36% since my warning that the stock could be heading for a correction that would be triggered by the banned pesticides scandal.
The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the United States and Canada, decreased 9% in April due primarily to heavy losses in the United States.
Aphria Inc (TSE:APH) is now the front-runner in the race to hit the billion-dollar valuation mark.
On April 20, 2017, Cowen and Company, a leading Wall Street investment bank, issued a report that shows the accelerated adoption of cannabis pressuring alcohol volumes, with beer most at risk.
Aphria Inc. has been soaring since its graduation to the TSX last month. The company now has a $1.1 billion market cap and could pass Canopy Growth Corp. with its $1.74 billion market cap over the next few months. There’s no question Canopy stock has slowed down when compared to its peers like Aphria and Aurora Cannabis Inc
This past week brought a first for the investment world — a medical marijuana electronic-traded fund (ETF) made its debut.
The Horizons Medical Marijuana Life Sciences ETF is slated to begin trading Tuesday on the Toronto Stock Exchange. It will include 11 Canadian-listed stocks and four listed in the United States.
Aphria Inc. is the newest weed company to graduate to the TSX. The stock has been faring better than its peers, Canopy Growth Corp. and Aurora Cannabis Inc. over the past few months.
LEAMINGTON, Ontario, March 27, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX:APH)(OTCQB:APHQF), through its subsidiary Aphria (Arizona) Inc., is pleased to announce that it made an additional investment of $3 million (USD) in Copperstate Farms Investors, LLC (“Investors”).
There are a number of big institutions, including mutual funds, pension funds, and investment banks, that use the TSX Composite and its sub-indices as performance benchmarks for their portfolios. The addition of Canopy to the index will introduce some new dimensions to the index’s performance.
Canopy Growth Corporation (TSX:WEED) is being added to the influential S&P/TSX Composite Index in another milestone for Canada’s fledgling marijuana industry.
SMITH FALLS, Ontario, Feb. 17, 2017 /Weed Wire/ — Canopy Growth Corporation (TSX: WEED) (“Canopy Growth” or the “Corporation”) announced that it has renewed the engagement agreement (“agreement”) with XIB Consulting Inc. (“XIB”) that the Corporation announced on April 7, 2016 and subsequently renewed October 7, 2016.
Investors are incredibly excited about Canopy Growth Corporation. But we’re now looking at a situation where the stock has increased quite aggressively thanks mostly to the belief that the future is bright. And there are still many investors sitting on the sidelines wondering if they should consider this company.
LEAMINGTON, Ontario, Feb. 6, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH) (OTCQB:APHQF) is pleased to announce it has received conditional approval from the Toronto Stock Exchange (the “TSX”) to graduate from the TSX Venture Exchange and list its common shares on the TSX.
On the face of it, 2017 may be the year to jump into the marijuana market to get a piece of what looks to be promising growth over the next few years.
As of Wednesday, traders on the Toronto Stock Exchange can buy and sell “WEED.”
SMITH FALLS, Ontario, Jan. 27, 2017 /Weed Wire/ — Canopy Growth Corporation (“Canopy Growth”) (TSX:CGC) and Mettrum Health Corp. (“Mettrum”) (TSX VENTURE:MT) (together, the “Companies”) are pleased to announce the successful results of the Special Meetings of Shareholders of Canopy Growth and Mettrum, held in Smiths Falls, Ontario and Toronto, Ontario, respectively, to approve Canopy Growth’s acquisition of Mettrum by way of a plan of arrangement (the “Arrangement”), as previously announced by the Companies on December 1, 2016.
SMITH FALLS, Ontario, Jan. 16, 2017 /Weed Wire/ — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: CGC) has closed the acquisition of the property at 1 Hershey Drive that currently houses Canopy Growth’s headquarters and the Tweed Inc. (Tweed) production facilities.